FGF21 promotes wound healing of rat brain microvascular endothelial cells through facilitating TNF-α-mediated VEGFA and ERK1/2 signaling pathway.
Abstract
[BACKGROUND] Wound healing is an essential physiological process in recovery after microsurgery.
[OBJECTIVES] To further understand the functions of fibroblast growth factor 21 (FGF21), the roles of this factor were examined and its correlations with inflammation, vascular endothelial growth factor A (VEGFA) and ERK1/2 signaling pathway activation were analyzed.
[MATERIAL AND METHODS] Rat brain microvascular endothelial cells (RBMECs) were treated with interleukin (IL)-1β and used for the experiments. Cell Counting Kit-8 (CCK-8) was used to detect the cell viability of RBMECs after treatment with IL-1β (1 ng/mL) and FGF21 or VEGFA overexpression, while changes in apoptosis were measured through flow cytometry. Migration was checked through the scratch test. FGF21 and VEGFA RNA expression was assessed using reverse-transcription quantitative polymerase chain reaction (RT-qPCR), which was also used to examine RNA expression of Bcl-2, Bax and caspase-3. After IL-1β treatment and FGF21 overexpression, tumor necrosis factor alpha (TNF-α) and tumor growth factor β1 (TGF-β1) proteins level were observed with enzyme-linked immunosorbent assay (ELISA), which was also applied to check the expression of ERK1/2 after overexpression of FGF21 and VEGFA. PD98059 (50 μM), an ERK1/2 inhibitor, was used to examine the roles of ERK1/2 in regulating cell viability and apoptosis.
[RESULTS] The IL-1β treatment significantly decreased the viability of RBMECs and TGF-β1, but promoted cell apoptosis and TNF-α expression. FGF21 was downregulated by IL-1β treatment but its overexpression enhanced the viability of RBMECs and TGF-β1 and ERK1/2 protein levels, and attenuated cell apoptosis and TNF-α. Upregulated TNF-α restrained cell viability and apoptosis of RBMECs after FGF21 overexpression, and its upregulation not only suppressed FGF21, but also VEGFA. Moreover, VEGFA suppression by TNF-α increased cell viability and ERK1/2 protein levels, and suppressed the apoptosis of RBMECs through its upregulation. However, PD98059 obstructed the functions of FGF21 and VEGFA.
[CONCLUSIONS] FGF21 promoted the cell viability of RBMECs through upregulating TNF-α-mediated VEGFA and ERK1/2 signaling.
[OBJECTIVES] To further understand the functions of fibroblast growth factor 21 (FGF21), the roles of this factor were examined and its correlations with inflammation, vascular endothelial growth factor A (VEGFA) and ERK1/2 signaling pathway activation were analyzed.
[MATERIAL AND METHODS] Rat brain microvascular endothelial cells (RBMECs) were treated with interleukin (IL)-1β and used for the experiments. Cell Counting Kit-8 (CCK-8) was used to detect the cell viability of RBMECs after treatment with IL-1β (1 ng/mL) and FGF21 or VEGFA overexpression, while changes in apoptosis were measured through flow cytometry. Migration was checked through the scratch test. FGF21 and VEGFA RNA expression was assessed using reverse-transcription quantitative polymerase chain reaction (RT-qPCR), which was also used to examine RNA expression of Bcl-2, Bax and caspase-3. After IL-1β treatment and FGF21 overexpression, tumor necrosis factor alpha (TNF-α) and tumor growth factor β1 (TGF-β1) proteins level were observed with enzyme-linked immunosorbent assay (ELISA), which was also applied to check the expression of ERK1/2 after overexpression of FGF21 and VEGFA. PD98059 (50 μM), an ERK1/2 inhibitor, was used to examine the roles of ERK1/2 in regulating cell viability and apoptosis.
[RESULTS] The IL-1β treatment significantly decreased the viability of RBMECs and TGF-β1, but promoted cell apoptosis and TNF-α expression. FGF21 was downregulated by IL-1β treatment but its overexpression enhanced the viability of RBMECs and TGF-β1 and ERK1/2 protein levels, and attenuated cell apoptosis and TNF-α. Upregulated TNF-α restrained cell viability and apoptosis of RBMECs after FGF21 overexpression, and its upregulation not only suppressed FGF21, but also VEGFA. Moreover, VEGFA suppression by TNF-α increased cell viability and ERK1/2 protein levels, and suppressed the apoptosis of RBMECs through its upregulation. However, PD98059 obstructed the functions of FGF21 and VEGFA.
[CONCLUSIONS] FGF21 promoted the cell viability of RBMECs through upregulating TNF-α-mediated VEGFA and ERK1/2 signaling.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | microvascular
|
미세수술 | dict | 2 | |
| 시술 | microsurgery
|
미세수술 | dict | 1 | |
| 해부 | RBMECs
→ Rat brain microvascular endothelial cells
|
scispacy | 1 | ||
| 해부 | Cell
|
scispacy | 1 | ||
| 합병증 | necrosis
|
괴사 | dict | 1 | |
| 합병증 | wound
|
scispacy | 1 | ||
| 약물 | CCK-8
→ Cell Counting Kit-8
|
scispacy | 1 | ||
| 약물 | RBMECs
→ Rat brain microvascular endothelial cells
|
scispacy | 1 | ||
| 약물 | PD98059
|
C0298346
PD 98059
|
scispacy | 1 | |
| 약물 | [BACKGROUND] Wound healing
|
scispacy | 1 | ||
| 약물 | [OBJECTIVES]
|
scispacy | 1 | ||
| 약물 | [MATERIAL AND METHODS] Rat brain microvascular endothelial cells
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] FGF21
|
scispacy | 1 | ||
| 질환 | inflammation
|
C0021368
Inflammation
|
scispacy | 1 | |
| 질환 | tumor necrosis
|
C0333516
Tumor necrosis
|
scispacy | 1 | |
| 질환 | TNF-α
|
scispacy | 1 | ||
| 질환 | tumor
|
C0027651
Neoplasms
|
scispacy | 1 | |
| 질환 | TGF-β1
→ tumor growth factor β1
|
C0040690
Transforming Growth Factor beta
|
scispacy | 1 | |
| 기타 | FGF21
→ fibroblast growth factor 21
|
scispacy | 1 | ||
| 기타 | rat brain microvascular endothelial cells
|
scispacy | 1 | ||
| 기타 | VEGFA
→ vascular endothelial growth factor A
|
scispacy | 1 | ||
| 기타 | ERK1/2
|
scispacy | 1 | ||
| 기타 | fibroblast growth factor 21
|
scispacy | 1 | ||
| 기타 | vascular endothelial growth factor A
|
scispacy | 1 | ||
| 기타 | interleukin
|
scispacy | 1 | ||
| 기타 | Bcl-2
|
scispacy | 1 | ||
| 기타 | Bax
|
scispacy | 1 | ||
| 기타 | caspase-3
|
scispacy | 1 | ||
| 기타 | tumor necrosis factor alpha
|
scispacy | 1 | ||
| 기타 | tumor growth factor β1
|
scispacy | 1 | ||
| 기타 | TNF-α
|
scispacy | 1 |
MeSH Terms
Animals; Apoptosis; Brain; Endothelial Cells; Fibroblast Growth Factors; MAP Kinase Signaling System; Rats; Signal Transduction; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Wound Healing
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Endodontic implications of hypercementosis: A systematic review of anatomical challenges and therapeutic strategies.
- Breast plastic surgery in perimenopausal and postmenopausal women: Menopause-informed counseling on screening, safety, and long-term breast health.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.
- Free flap reconstruction of a cast-related pressure ulcer in a pediatric patient with spinal muscular atrophy.
- Characterization of Trimmed Nerve Morphology Using High-Resolution Imaging: Comparison of Three Surgical Instruments.